Paolo Tarantino/X
Feb 25, 2025, 09:33
Paolo Tarantino: Does Trop2 expression matter in the context of Dato-DXd treatment of mBC?
Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute, shared a post on X:
“Does Trop2 expression matter in the context of Dato-DXd treatment of mBC?
Data from the FDA review shows no association between Trop2 expression and outcomes with Dato-DXd in TB01.
The mechanism of action of modern ADCs remains far from being elucidated.”
More posts featuring Paolo Tarantino.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 19:09
Apr 1, 2025, 18:48
Apr 1, 2025, 18:37
Apr 1, 2025, 18:26
Apr 1, 2025, 18:22